Age-related macular degeneration (AMD) is the leading cause of severe vision loss in elderly individuals aged >55 years in developed countries [1]. Approximately 196 million individuals, or 8.69% of the global population, are affected by AMD. With the increase in life expectancy and population ageing, this number is expected to rise to 288 million by […]
Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in the population aged over 55 years worldwide, with the number of affected individuals projected to reach 288 million by 2040 [1,2]. The advanced stage of AMD manifests in two forms, including geographic atrophy (dry) and neovascular (wet) AMD. Currently, there is no […]
Purpose: Vision‐threatening diabetic retinopathy (VTDR) poses significant blindness risks and the study aimed to identify the impact of psychological factors on its ocular outcomes. Methods: This retrospective cohort study enrolled 782 VTDR patients from three ophthalmological centers (2018–2021). DR severity was graded using ETDRS criteria. Primary outcomes included tractional retinal detachment (TRD) involving the fovea, neovascular glaucoma (NVG), final best‐corrected visual acuity (BCVA) <0.3, and recurrent vitreous hemorrhage (VH). Anxiety and depression were assessed via the hospital anxiety and depression scale (HADS). Univariable and multivariable logistic regression evaluated the associations between HADS scores and ocular outcomes. Results: After a median follow‐up of 24.8 months, depressive symptoms (HADS‐D ≥8) were associated with higher rates of BCVA <0.3 (67.8% vs. 57.2%, p = 0.033) and NVG (13.6% vs. 6.9%, p = 0.020). Recurrent VH was more frequent in patients with anxiety (21.0% vs. 10.6%, p = 0.031) or depression (20.3% vs. 10.7%, p = 0.045). Multivariable logistic analysis revealed that each 1‐point increase in HADS‐D score significantly increased adjusted odds of TRD (aOR = 1.06, 95% CI: 1.01−1.11), BCVA <0.3 (aOR = 1.07, 95% CI: 1.02−1.11), recurrent VH (aOR = 1.09, 95% CI: 1.02−1.17), and NVG (aOR = 1.10, 95% CI: 1.03−1.17; all p < 0.05). There was a consistent positive gradient between HADS severity and adverse outcomes. Conclusion: Depressive symptoms are independently associated with worse ocular prognoses in VTDR patients. Systematic psychological screening and intervention is essential to mitigate vision deterioration risk in this population.